Press-release for stocks publishing date 2022 - 04

Prices are updated after-hours

Amneal Achieves Second U.S. Biosimilars Approval with ALYMSYS® (bevacizumab-maly)
Published: 2022-04-13 (Crawled : 21:00) - biospace.com/
AMRX | $5.4 0.56% 0.56% 1.4M

| 25.17% | O: -0.7% H: 6.46% C: 1.88%
alymsys approval

BriaCell Receives FDA Fast Track Approval for Targeted Breast Cancer Immunotherapy
Published: 2022-04-13 (Crawled : 17:00) - biospace.com/
BCTX | $2.19 -5.6% -5.94% 140K

| -72.15% | O: 11.0% H: 2.27% C: -17.91%
fda immunotherapy approval cancer breast cancer

BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 20 Years Since First U.S. FDA Approval
Published: 2022-04-13 (Crawled : 16:00) - biospace.com/
ABBV | News | $169.54 0.98% -0.91% 4.1M

| 0.35% | O: -1.38% H: 0.0% C: -3.67%
botox fda approval

| 0.0% | O: 2.88% H: 0.4% C: 0.0%
BFRI | $1.48 2.42% 2.36% 54K

| -98.04% | O: 1.08% H: 63.64% C: 32.62%
ameluz fda pharma contract approval

Insurtech Startup Honeycomb Gains Approval to Write Policies in Wisconsin
Published: 2022-04-13 (Crawled : 13:00) - prnewswire.com
SPNT F | $12.3 0.99% 0.0% 380K

| 89.42% | O: 0.31% H: 2.33% C: 1.4%
approval

| 22.71% | O: 1.21% H: 5.01% C: 3.58%
treatment drug dextenza ocular approval therapeutics

78%

22%

MTTR | News M | $4.6 164.37% 62.17% 28M

AGBA | $2.94 135.2% 57.48% 66M

EDBL | News | $6.46 71.81% 41.8% 2M

MTC | $2.25 44.23% 30.67% 6M

OPRT | News | $3.175 41.11% 29.13% 12M

SHIM | $3.05 35.56% 26.23% 1.1M

HKIT | $1.345 31.86% 24.16% 390K

ABVC | $1.36 30.77% 23.53% 7.4M

OST | $0.512 28.0% 21.88% 290K

POET | $1.59 27.2% 21.38% 4.2M

Save your searches and get alerts when important news are released.